Actionable trade ideas with defined risk and time horizons.
Curated trade ideas across equities, options, and other instruments, featuring clear directional bias, time horizon, and risk considerations. Trade ideas are designed to align market context, technical structure, and risk management principles.
12,229 total articles
Olin's share price has been punished by an unplanned vinyl chloride monomer plant shutdown and legal noise around the Huntsman merger. The disruption is a one-time cash hit of about $40 million to Q2 adjusted EBITDA with an estimated $20 million follow-through in Q3. At $17.29, the stock is trading near its 52-week low, yields 4.6%, and still gener…
Alvopetro Energy (ALVOF) trades at $7.10 with neutral momentum and a history of elevated short activity. Management has positioned the name as high-margin with a covered dividend. Liquidity and opacity are real risks, but the technical setup, modest RSI, and one-day days-to-cover give a defined risk-reward for a 45-trading-day swing trade.
Meta owns one of the largest AI compute footprints on the planet. If management moves aggressively to rent spare GPU capacity through inference/finetune marketplaces and third-party cloud deals, revenue upside and margin expansion can follow quickly. This is a mid-term trade: enter at $450, stop $390, target $540 on a 45 trading day horizon, with a…
Bonterra Energy (BNEFF) is an overtly levered oil & gas-style play trading on the OTC market around $4. Technicals are neutral-to-bullish, short interest has collapsed from spring highs and short-volume spikes show continued active shorting on rallies. If commodity prices stay supportive, this structure can produce a rapid move higher. This is a hi…
Clover Health is an actionable long thanks to accelerating Medicare Advantage membership, demonstrable AI-driven care improvements, improving free cash flow and a valuation that prices growth modestly. This trade idea lays out a mid-term plan centered on enrollment catalysts and recurring care-management economics while flagging regulatory, data an…
Stantec's $9.0B backlog, double-digit EPS growth and 17%+ adjusted EBITDA margins create a runway for continued organic growth. The stock trades at ~22.8x earnings with EV/EBITDA ~11.7x and an enterprise value of ~$9.34B, leaving room for upside if management converts backlog into revenue and sustains margins. We recommend buying STN with a clear e…
TG Therapeutics has transitioned from small-cap promise to commercial-stage execution. BRIUMVI's accelerating sales, upgraded 2025 guidance and an active product expansion roadmap justify upgrading the rating to Buy. This trade idea lays out an entry at the current level, a protective stop and a mid-term target driven by continued uptake and upcomi…
Symbotic is a hardware-led automation platform with a $22.3 billion backlog, 23% YoY revenue growth in Q2 2026, a material free cash flow stream, and recent software acquisitions that convert lumpy installations into higher-margin recurring value. We view the company as primed for an eFY2027 inflection in revenue conversion and margin expansion; in…
<p>Wheaton Precious Metals (WPM) reported record production and cash flow and looks to have its near-term growth pipeline effectively funded through existing streaming contracts and cash. That combination — demonstrated execution plus capital-light growth — supports a constructive trade. The plan below targets upside toward prior resistance while k…
AMC is trading at $2.66 with clear operational momentum from stronger attendance and a cleaner debt profile after recent refinancing. The stock can rally near-term, but the dominant risk remains share issuance. This trade sets a defined entry, stop and target while emphasizing active monitoring of outstanding shares and any new equity deals.
Ondas (ONDS) is growing fast: recent contract wins and an acquisition lift 2026 revenue targets well into the hundreds of millions, yet the company remains unprofitable and cash flow negative. For traders willing to accept volatility, a defined long trade with a clear stop and target offers attractive asymmetric upside while limiting downside if ex…
Sezzle's merchant-facing Sezzle Anywhere checkout and consumer-facing Sezzle Cash product create a path to disproportionate EBITDA growth as volumes scale. The market appears to be underestimating operating leverage from higher take rates, fixed-cost absorption, and cross-sell between products. This trade targets the re-rating that should follow ac…
Arteris (AIP) has pulled back from its 52-week highs and is carving a consolidation base around $23. The company's steady wins in automotive and cybersecurity IP, plus a recent acquisition and expanded Arm partnership, give a fundamental backdrop for a swing trade. Valuation is lofty vs. current profitability, so the trade is price-action driven wi…
Royalty Pharma (RPRX) is a cash-generating royalty vehicle with a diversified portfolio of commercial drugs and a growing development pipeline. At roughly $62 per share, the stock trades with an enterprise value to free cash flow of ~12x despite steady FCF of nearly $3.0B and visible catalysts (Asia expansion, Teva collaboration, new translational …
Navitas (NVTS) is a high-risk, high-upside trade: the company’s pivot from consumer GaN chargers to high-power, on-board data-center power delivery - accelerated by the acquisition of Claros - could turn a sub-$15M quarterly revenue stream into a meaningful AI-power platform. Market-cap and valuation metrics already price in extreme growth; this tr…
HPE has become an on-premises AI infrastructure play with a near-record backlog and improving fundamentals. The chart shows a bull-flag consolidation above $50 after a strong rally; with Q3 results and continued AI spending as catalysts, a tactical long targeting $80 offers asymmetric upside into the next earnings cycle.
Mach Natural Resources (MNR) is trading below recent moving averages after an oil pullback, but the partnership still generates meaningful free cash flow ($347.6M) and carries a reasonable valuation (EV/EBITDA ~5). With a current yield near 14% and a balance sheet that shows modest leverage (debt/equity ~0.63), this is a tactical long (swing) idea:…
Nebius (NBIS) is an infrastructure-first play in the next wave of cloud AI. The company just reported explosive top-line growth, materially shortened contract payback, and multi-billion-dollar customer commitments. That combination makes NBIS a high-upside tactical long over the next 45 trading days, but the stock carries elevated valuation and cap…
Nebius is proving it can be more than an AI GPU provider. Recent contract wins, a compressed payback period near 22 months, and 2025 profitability combine with hyper-growth to create an actionable long opportunity. Valuation is rich and capital intensity remains high, so this trade is for disciplined investors with a high-risk tolerance and a clear…
OneMain’s fundamentals remain solid: meaningful free cash flow, 23% return on equity and a ~6.7% yield support valuation as peers tighten credit. At the same time, an ongoing multi-state litigation and elevated leverage justify a downgrade to Neutral. For active traders, a mid-term (45 trading days) buy-the-dip trade with a defined stop and target …
Pursuit Attractions & Hospitality (PRSU) offers a tradeable long setup around $48.93 that aims to capture re-rating into the company’s 52-week high. The business benefits from premium, experience-driven tourism across differentiated destinations; liquidity, moderate leverage, and a manageable short-interest profile support a mid-term rebound. Valua…
Nano Labs (NA) is a microcap fabless chip and AI-infrastructure play trading at a $48.4M market cap. Recent product launches, a North America MOU for AI data centers, and meaningful insider buying sit alongside very high short interest and improving technicals. This trade idea frames a speculative long for a mid-term horizon (45 trading days) with …
Exor N.V. is a capital-allocating holding company with large, liquid stakes in high-quality businesses. The shares trade materially below our conservative estimate of sum-of-parts value, creating a high-conviction, asymmetric trade: buy at $55 with a stop at $45 and a target of $110 over a 180-trading-day horizon.
Tenaz Energy is executing a brownfield-focused growth plan in the North Sea that should produce cash flow upside with lower execution risk versus greenfield projects. This trade idea targets a re-rating tied to near-term production milestones, potential M&A interest, and winter oil demand. Enter at $1.20, target $2.40, stop $0.90 over a 180-trading…
Geely is transitioning from China-centric auto maker to a global automotive group anchored by modular EV platforms, international joint ventures, and rising manufacturing scale. This trade idea targets structural EV adoption and margin recovery while recognizing execution and macro risks.
